Join
Live feed
·
PRReleasevia Quantisnow
MeiraGTx Holdings plc logo

Graviton BioScience Announces Clearance of Investigational New Drug (IND) for GV101 for the Treatment of Friedreich's Ataxia

ByQuantisnow·Wall Street's wire, on your screen.
MGTX· MeiraGTx Holdings plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MGTX (MeiraGTx Holdings plc) and more on Quantisnow.